1. Home
  2. MOLN vs HITI Comparison

MOLN vs HITI Comparison

Compare MOLN & HITI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • HITI
  • Stock Information
  • Founded
  • MOLN 2004
  • HITI 2009
  • Country
  • MOLN Switzerland
  • HITI Canada
  • Employees
  • MOLN N/A
  • HITI N/A
  • Industry
  • MOLN
  • HITI
  • Sector
  • MOLN
  • HITI
  • Exchange
  • MOLN Nasdaq
  • HITI Nasdaq
  • Market Cap
  • MOLN 183.2M
  • HITI 217.9M
  • IPO Year
  • MOLN 2021
  • HITI N/A
  • Fundamental
  • Price
  • MOLN $3.81
  • HITI $2.25
  • Analyst Decision
  • MOLN
  • HITI Strong Buy
  • Analyst Count
  • MOLN 0
  • HITI 1
  • Target Price
  • MOLN N/A
  • HITI $4.50
  • AVG Volume (30 Days)
  • MOLN 3.2K
  • HITI 293.6K
  • Earning Date
  • MOLN 05-15-2025
  • HITI 06-12-2025
  • Dividend Yield
  • MOLN N/A
  • HITI N/A
  • EPS Growth
  • MOLN N/A
  • HITI N/A
  • EPS
  • MOLN N/A
  • HITI N/A
  • Revenue
  • MOLN $2,525,030.00
  • HITI $370,825,186.00
  • Revenue This Year
  • MOLN N/A
  • HITI $12.43
  • Revenue Next Year
  • MOLN $866.67
  • HITI $11.39
  • P/E Ratio
  • MOLN N/A
  • HITI N/A
  • Revenue Growth
  • MOLN N/A
  • HITI 7.84
  • 52 Week Low
  • MOLN $3.36
  • HITI $1.57
  • 52 Week High
  • MOLN $12.70
  • HITI $3.62
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 46.07
  • HITI 45.80
  • Support Level
  • MOLN $3.58
  • HITI $2.17
  • Resistance Level
  • MOLN $4.11
  • HITI $2.35
  • Average True Range (ATR)
  • MOLN 0.12
  • HITI 0.08
  • MACD
  • MOLN -0.02
  • HITI -0.02
  • Stochastic Oscillator
  • MOLN 33.74
  • HITI 27.34

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, Famous Brandz, and others. The company's reportable operating segments are; Bricks and mortar which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada followed by the United States of America, and other international markets.

Share on Social Networks: